9/22/2025

Pfizer Inc. acquires Metsera, Inc. to re-enter the obesity drug market. Click for my look at PFZ and MTSR stock and where I see value in the weight loss sector.

Source: SeekingAlpha

9/21/2025

The agency’s crackdown represents a significant rise in scrutiny of pharmaceutical ads in recent years.

Source: Yahoo

9/20/2025

AstraZeneca (LSE:AZN) has been catching the eyes of investors lately, not for a single headline-grabbing event but as part of a broader conversation around its valuation. The stock’s movement might seem subtle at first glance, yet there is a real sense that something is changing under the surface. For anyone weighing whether this is a sign to act, it is worth taking a closer look at what the stock’s performance signals and whether it presents a window of opportunity or a warning to...

Source: Yahoo

9/20/2025

50 Companies to Watch for 2025 spotlight AI, EVs & dividends. See why 13 'safer' stocks may offer 17.63% gains & ideal yields for smart investing.

Source: SeekingAlpha

9/19/2025

Astrazeneca (AZN) closed at $76.28 in the latest trading session, marking a -1.03% move from the prior day.

Source: Yahoo

9/19/2025

According to DataM Intelligence, the global liver cancer therapeutics market size was valued at US$3.36 billion in 2024 and is expected to reach US$13.16 billion by 2033, growing at a CAGR of 16.5% during the forecast period 2025-2033.

Source: Yahoo

9/19/2025

AstraZeneca and Pfizer both boast strong oncology pipelines, but growth paths, dividends and challenges set them apart for investors.

Source: Yahoo

9/19/2025

These three promising biotech stocks are poised for growth or potential buyouts. Here's what investors need to know.

Source: SeekingAlpha

9/19/2025

AstraZeneca is a leading global pharmaceutical company with strong growth in oncology, diversified revenues, and a robust pipeline. Click to read why AZN is a Buy.

Source: SeekingAlpha

9/18/2025

European equities traded in the US as American depositary receipts were tracking higher Thursday mor

Source: Yahoo

9/18/2025

In this article, we will be taking a look at the 13 Most Oversold Healthcare Stocks So Far in 2025. Danaher Corporation is one of them. Danaher Corporation (NYSE:DHR), a global leader in life sciences and diagnostics, continues to advance its bioprocessing, diagnostics, and life sciences segments through innovation and strategic partnerships. In Q2 2025, […]

Source: Yahoo

9/18/2025

Results from a pre-specified interim analysis of the Phase III TULIP-SC trial in patients with systemic lupus erythematosus showed that the subcutaneous administration of AstraZeneca’s (AZN) Saphnelo demonstrated a statistically significant and clinically meaningful reduction in disease activity compared to placebo. The safety profile observed in the interim analysis was consistent with the known clinical profile of Saphnelo administered as an intravenous infusion. The TULIP-SC trial evaluated t

Source: Yahoo

9/18/2025

WILMINGTON, Del., September 18, 2025--AIRSUPRA’s US Prescribing Information now includes clinically meaningful evidence from the BATURA study in patients with mild asthma.1 The BATURA Phase IIIb trial, which evaluated severe exacerbation risk reduction, examined the efficacy of as-needed AIRSUPRA compared to as-needed albuterol,2 the most commonly used rescue medication for asthma in the US. The BATURA trial demonstrated treatment with AIRSUPRA significantly reduced the risk of a severe exacerba

Source: Yahoo

9/18/2025

The safety profile of the SC administration of the antibody aligned with the profile observed in IV infusions.

Source: Yahoo

9/18/2025

Innate Pharma SA (IPHA) reports strong cash position and progress in clinical assets, while navigating organizational restructuring and competitive pressures.

Source: Yahoo

9/17/2025

COLLEGE PARK, Md., September 17, 2025--IonQ (NYSE: IONQ), the leader in the quantum computing and networking industries, today announced the signing of a memorandum of understanding (MOU) with the U.S. Department of Energy (DOE) to advance the development and deployment of quantum technologies in space. The agreement supports the DOE’s growing Quantum in Space (QIS) initiative and outlines IonQ’s role in demonstrating quantum ground-to-orbit-to-ground capabilities.

Source: Yahoo

9/17/2025

Health care stocks were edging up late Wednesday afternoon, with the NYSE Health Care Index up 0.2%

Source: Yahoo

9/17/2025

Find insight on Novo Nordisk, EssilorLuxottica and more in the latest Market Talks covering Health Care.

Source: Yahoo

9/17/2025

The Dow Jones Industrial Average was up in late-morning trading Wednesday, while the S&P 500 and the

Source: Yahoo

9/17/2025

Health care stocks were rising premarket Wednesday, with the iShares Biotechnology ETF (IBB) 0.5% hi

Source: Yahoo